The laboratory has developed methods to assess the genetic risk of malignancies based on a combination of allelic polymorphisms of repair genes, apoptosis, cell cycle, immune and antioxidant systems, as well as single cell DNA studies to evaluate hematopoietic stem cells of exposed individuals.
Predictors of leukemia in exposed people have been developed and implemented in the URCRM Clinical department.